Memorises Bio is a therapeutic antibody discovery company spun out of Memo Therapeutics. We investigate human immune responses and translate them into therapeutic antibodies, combining deep repertoire capture with large-scale functional screening.
Cooperation possibilities
Our proprietary Dropzylla® platform captures human antibody repertoires at exceptional depth and converts them into biobank libraries for large-scale functional screening. 2 platform-derived antibodies have advanced into clinical development.
